- Home
- NCNA vs CPHI Comparison
NCNA vs CPHI Comparison
Compare NCNA & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- CPHI
- Stock Information
- Founded
- NCNA 1997
- CPHI N/A
- Country
- NCNA United Kingdom
- CPHI China
- Employees
- NCNA N/A
- CPHI N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- NCNA Health Care
- CPHI Health Care
- Exchange
- NCNA Nasdaq
- CPHI Nasdaq
- Market Cap
- NCNA 4.5M
- CPHI 4.5M
- IPO Year
- NCNA 2017
- CPHI N/A
- Fundamental
- Price
- NCNA $0.65
- CPHI $1.65
- Analyst Decision
- NCNA Buy
- CPHI
- Analyst Count
- NCNA 2
- CPHI 0
- Target Price
- NCNA $25.00
- CPHI N/A
- AVG Volume (30 Days)
- NCNA 140.2K
- CPHI 119.7K
- Earning Date
- NCNA 05-15-2025
- CPHI 05-14-2025
- Dividend Yield
- NCNA N/A
- CPHI N/A
- EPS Growth
- NCNA N/A
- CPHI N/A
- EPS
- NCNA N/A
- CPHI N/A
- Revenue
- NCNA N/A
- CPHI $4,528,929.00
- Revenue This Year
- NCNA N/A
- CPHI N/A
- Revenue Next Year
- NCNA N/A
- CPHI N/A
- P/E Ratio
- NCNA N/A
- CPHI N/A
- Revenue Growth
- NCNA N/A
- CPHI N/A
- 52 Week Low
- NCNA $0.69
- CPHI $1.20
- 52 Week High
- NCNA $10.79
- CPHI $4.10
- Technical
- Relative Strength Index (RSI)
- NCNA 39.85
- CPHI 42.78
- Support Level
- NCNA $0.71
- CPHI $1.34
- Resistance Level
- NCNA $0.89
- CPHI $1.71
- Average True Range (ATR)
- NCNA 0.09
- CPHI 0.28
- MACD
- NCNA -0.00
- CPHI 0.00
- Stochastic Oscillator
- NCNA 12.68
- CPHI 37.38
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.